Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

<< Previous

Bullboard Posts

Next >>

Post by Metalsguy1on Apr 01, 2022 12:13pm

188 Views

Post# 34567559

Riddle me this....

what do you get after $30 million and 5 quarters in SVA. $30,000,001.25 less expenses. I think we have gone way beyond foot dragging...it is almost as if they took a knock off course from Pacifica University entitled the 5 habits of Moderately Effective Sales Clerks.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec